Table 2.
Relationship Between uPAR Content in Tumor Tissues and Clinicopathological Features
| Feature | Cases | uPAR (ng/100 mg protein) | P |
|---|---|---|---|
| TNM stage | |||
| I | 16 | 50.23 ± 12.34* | <0.05 |
| IIa | 40 | 82.36 ± 29.35 | |
| Lymph node metastasis | |||
| Yes | 24 | 88.56 ± 29.65 | <0.05 |
| No | 32 | 50.23 ± 20.30 | |
| Degree of infiltration | |||
| Myometrial invasion 2/3 | 26 | 68.65 ± 27.68 | >0.05 |
| Myometrial invasion <2/3 | 30 | 80.58 ± 30.16 | |
| Vessel thrombosis | |||
| Yes | 13 | 76.59 ± 30.64 | >0.05 |
| No | 43 | 68.42 ± 21.71 | |
| Pathological classification | |||
| Well differentiated | 12 | 48.69 ± 30.36 | |
| Moderately differentiated | 23 | 48.23 ± 19.68 | |
| Poorly differentiated | 21 | 93.41 ± 24.25** | <0.05 |
*Compared with II phase.